MediciNova, Inc. (4875.T)
JPY 214.0
(0.47%)
JPY 214.0
(0.47%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -8.57 Million USD | 34.59% |
| 2022 | -1.85 Billion USD | -58.12% |
| 2021 | -1.17 Billion USD | 18.18% |
| 2020 | -1.43 Billion USD | -10949.59% |
| 2019 | -12.94 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -416.91 Million USD | -43.49% |
| 2024 Q2 | -2.62 Million USD | 99.37% |
| 2023 Q4 | -290.54 Million USD | -168.87% |
| 2023 FY | -1.21 Billion USD | 34.59% |
| 2023 Q3 | -108.06 Million USD | 73.93% |
| 2023 Q2 | -414.52 Million USD | -6.94% |
| 2023 Q1 | -387.61 Million USD | -12813.95% |
| 2022 FY | -1.85 Billion USD | -58.12% |
| 2022 Q4 | -3 Million USD | 0.0% |
| 2021 FY | -1.17 Billion USD | 18.18% |
| 2020 FY | -1.43 Billion USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 384 Million JPY | 102.232% |
| PRISM BioLab Co.,LTD | -526.91 Million JPY | 98.373% |
| GNI Group Ltd. | 8.09 Billion JPY | 100.106% |
| Linical Co., Ltd. | 338.26 Million JPY | 102.534% |
| Trans Genic Inc. | 4.08 Million JPY | 309.829% |
| MEDINET Co., Ltd. | -1.43 Billion JPY | 99.404% |
| Soiken Holdings Inc. | -662.2 Million JPY | 98.706% |
| Cytori Cell Research Institute, Inc. | 138.15 Million JPY | 106.204% |
| AnGes, Inc. | -7.43 Billion JPY | 99.885% |
| OncoTherapy Science, Inc. | -1.28 Billion JPY | 99.335% |
| Nxera Pharma Co., Ltd. | -7.19 Billion JPY | 99.881% |
| Immuno-Biological Laboratories Co., Ltd. | 186.69 Million JPY | 104.591% |
| NanoCarrier Co., Ltd. | -780 Million JPY | 98.901% |
| Carna Biosciences, Inc. | -1.15 Billion JPY | 99.257% |
| CanBas Co., Ltd. | -1.2 Billion JPY | 99.291% |
| D. Western Therapeutics Institute, Inc. | -812.41 Million JPY | 98.945% |
| RaQualia Pharma Inc. | -323.66 Million JPY | 97.352% |
| Chiome Bioscience Inc. | -1.22 Billion JPY | 99.297% |
| Kidswell Bio Corporation | -1.42 Billion JPY | 99.397% |
| PeptiDream Inc. | 3.03 Billion JPY | 100.282% |
| Oncolys BioPharma Inc. | -1.93 Billion JPY | 99.558% |
| Ribomic Inc. | -1.02 Billion JPY | 99.163% |
| SanBio Company Limited | -2.64 Billion JPY | 99.676% |
| Healios K.K. | -3.82 Billion JPY | 99.776% |
| BrightPath Biotherapeutics Co., Ltd. | -1.16 Billion JPY | 99.266% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.48 Billion JPY | 99.425% |
| Delta-Fly Pharma, Inc. | -1.42 Billion JPY | 99.4% |
| StemRIM | -2.02 Billion JPY | 99.576% |
| CellSource Co., Ltd. | 923.14 Million JPY | 100.929% |
| FunPep Company Limited | -933.41 Million JPY | 99.082% |
| Kringle Pharma, Inc. | -854.15 Million JPY | 98.996% |
| Stella Pharma Corporation | -763.74 Million JPY | 98.878% |
| TMS Co., Ltd. | -960.04 Million JPY | 99.107% |
| Noile-Immune Biotech Inc. | -1.13 Billion JPY | 99.241% |
| Cuorips Inc. | -632.18 Million JPY | 98.644% |
| K Pharma,Inc. | 260.33 Million JPY | 103.293% |
| Takara Bio Inc. | 1.48 Billion JPY | 100.579% |
| ReproCELL Incorporated | -31.41 Million JPY | 72.715% |
| PhoenixBio Co., Ltd. | 26.37 Million JPY | 132.495% |
| StemCell Institute Inc. | 310.98 Million JPY | 102.756% |
| Japan Tissue Engineering Co., Ltd. | 143.16 Million JPY | 105.987% |
| CellSeed Inc. | -846.53 Million JPY | 98.987% |